Major clinical guidelines recommend cognitive behavioral therapy for insomnia as the first-line treatment for chronic insomnia in adults, with medication considered when CBT-I is unavailable, insufficient, or when short-term pharmacological support is clinically indicated.
How they differ
- Speed. Hypnotics act on the first night. CBT-I generally produces meaningful change within two to four weeks.
- Durability. CBT-I gains persist after treatment ends. Medication effects generally stop when the medication stops.
- Mechanism. CBT-I changes the behaviors, timing, and arousal that maintain insomnia. Medication suppresses the symptom.
- Risk profile. Sedative-hypnotics carry considerations including next-day impairment, tolerance, dependence, and interactions, which vary by agent and by patient.
They are not mutually exclusive
Many people begin CBT-I while taking a sleep medication. Behavioral treatment can be delivered alongside medication and is frequently the foundation for a later, physician-led taper. Medication decisions — starting, adjusting, or discontinuing — are made by the prescribing physician; behavioral care is coordinated with the prescriber when appropriate.
References
- Qaseem A, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133.
- Riemann D, et al. European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research. 2023;32(6):e14035.
Written and reviewed by Christine Mason, PhD, DBSM, health psychologist board-certified in behavioral sleep medicine. Published August 25, 2026. Last reviewed August 25, 2026.
Related reading